How many coins are like $NEAR ? While the broader market is falling, it is rising against the trend, absorbing all selling pressure, and is expected to break out of the sideways consolidation range and move toward the $7 mark. Long entry: 5.25-5.35 Stop-loss: 4.95 Take-profit: 5.65-5.90.-6.20.-7.

$XAU Gold has crashed! Brothers who chased longs at 4300, is your position still alive? Don’t panic—you can still get out! The most detailed explanation!
Why the plunge? Don’t listen to random nonsense about the news—the core issue is just one word: debt.
U.S. Treasury bond interest rates have surged above 5.3%, the highest since 2002. You can earn more by keeping money in the bank than holding gold, so the big money has all fled. Look at the data: whales’ average long entry is 4293, and they are now sitting on $7.39 million in unrealized losses. Only 33% of the 133 whales are profitable. Fund

The most unusual detail in today’s market is not on the top losers list, but in the moving-average structure of $MUB
: the price at 1080.64 has moved above MA20 (1075.44), yet remains capped by MA5 (1084.26), while the MACD histogram remains bearish at -0.6377. The price rose 3.86%, but the indicators failed to keep up—this is a typical case of “price leading, momentum lagging,” and also the first lesson in determining whether a trend is healthy: a bullish moving-average alignment does not equal a healthy trend; the key is the price’s relative position against the short-term moving averages an

$ZEC Feeling great, feeling great—profited from the idea shared this morning by the time I woke up at noon. I’ll wait for an opportunity to enter the next wave!!!#GateMoney正式上线

After XRP touched a low of 1.3865, a potential short-term mean-reversion trading opportunity emerged, supported by a bullish divergence in the 15-minute RSI. The 1-hour RSI(12) is 31.08, indicating that the asset is severely oversold and could rebound in the short term to the MA7 resistance level at 1.4103. Go long now $XR .
Entry range: 1.3875 - 1.4005Target 1: 1.4583Target 2: 1.5097Stop-loss: 1.3459Click here to trade 👇👇👇Notably:$BT : Current price 82,892.5 - 24-hour change: -1.45%
$W : Current price 0.016759 - 24-hour change: +15.41%.

100,000 new
Guys, is that enough to spend?

Hyperliquid Events are the Best
Thanks @hypurr_co for organizing, you just outdid yourself!

Latest Web3 Trends: The RWA Narrative and ONDO Analysis
Among current Web3 trends, the tokenization of Real World Assets (RWA) represents a significant shift in capital allocation. This post examines the RWA sector and provides a technical and fundamental analysis of ONDO, a leading project in this category.
Technical Analysis (ONDO/USDT)
On the weekly timeframe (1W), ONDO is priced at 0.4662 USDT. The historical high is 2.1444, followed by a correction to a low of 0.1755. The asset is currently consolidating above the 0.40 support level.
· Weekly Indicators: Bollinger Bands show an upper band

$BTC Yesterday's strategy:
Went long on BTC near 83550 and were prompted to close near 83900, successfully turning a profit.
Went long on SNDK near 1626.3, entering near the lowest point; it rebounded to around 1733 at the high, successfully turning a profit.

#SamsungQ3OperatingProfitSurges782.5% Samsung Q3 Operating Profit Surges 782.5% 📈
Samsung Electronics has delivered a remarkable jump in third-quarter operating profit, surging 782.5% year over year. The sharp improvement highlights a significant recovery in profitability and renewed strength across key areas of the business.
Strong demand for advanced semiconductors and memory products remains an important factor for the broader technology sector. For investors, Samsung’s performance also offers a useful signal about the health of the global chip cycle and ongoing demand for AI-related infra

I warned all my subs that liquidity will rotate into the MAG 7.
$MAGS just made new ATH and got clear blue sky.
$GOOG $TSLA $AMZN $MSFT $AAPL $NVDA $META
Gave them the bottom on all of these. Now we are waiting for Tesla to pump.

this is a stock bot focused on projects with strong fundamentals, designed for mid- to long-term traders.
with $sol and #sui
#aapl #nvda $tsla $googl #crypto #stocks

Are short sellers panicking? $SNDK Ten million in liquidations above—Bai Yue teaches you how to precisely snipe the market makers!
Fund flows may be a scam, but the whales' $11 million in real money doesn't lie!
News: This morning, two whales placed $11 million buy orders for SNDK, with the heavy-position zone at 1664-1680. One account opened a position directly after taking substantial profits on its DRAM short, while another long position with an average price of $1815 is currently at an unrealized loss and adding to the position. The market makers' intention to defend the price is obvious.

🔥 What’s worth talking about today? Gate Square trending topics are live!
🔹Fed September minutes lean hawkish, keeping another rate hike on the table — what does this mean for $BTC and US stocks?
🔹Samsung Q3 operating profit surges 782.5% — how much further can the AI and memory-chip cycle run?
🔹Robinhood adds $25M in $BTC to its balance sheet — are financial platforms becoming the next wave of corporate Bitcoin buyers?
🔹Hyperliquid’s perpetual OI market share hits a record 11.9% — are on-chain derivatives taking meaningful share from CEXs?
🔥 Headline of the day: Gate Money is officially

Ethereum strategy delivered as expected;
Early morning alert: The rebound is merely a pause during the decline. Short if the rebound reaches the 2570-2600 resistance zone.
The price rebounded to 2586 before facing resistance and retreating, reaching a low near 2543 and providing 43 points of room.
Refuse to mistake a recovery for a reversal. Accurately identify resistance levels and position in line with the trend; the predictions have materialized one by one.$BTC

Google-affiliated AI pharma company Isomorphic Labs’ new valuation: $40–50 billion, roughly 3x TEM+RXRX+SDGR
1｜What the company has now
- UK company’s 2025 annual report: operating revenue of 0; payments from pharma partnerships recorded as other income of £55.23 million; R&D expenses of £190 million; net loss of £159 million; average headcount of 225.
- Its key cards are pharma partnerships: Eli Lilly $LLY with milestones of up to $1.7 billion, Novartis $NVS up to $1.2 billion, and it also signed Johnson & Johnson $JNJ this January. Milestones are installment payments that pharma companies